Daré Bioscience logo
Daré Bioscience DARE
$ 3.13 -0.95%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Daré Bioscience Financial Ratios 2011-2025 | DARE

Annual Financial Ratios Daré Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.4 -2.8 -3.2 -0.0 -1.2 -0.5 -0.6 -0.6 -1.5 -4.8 - - -

P/S

15.2 8.5 - - - - - 28.6 - 1411.2 - - -

EPS

-0.3 -0.4 -0.6 -0.9 -1.0 1.6 3.6 -1.4 -1.6 -1.6 -25.1 -36.4 -

EV (Enterprise Value)

58.6 M 83.5 M 87.7 M 75.4 M 19.8 M 2.86 M 357 K 46.4 M 14.6 M 69.8 M 4.13 M 81 M -

EBITDA per Share

-0.35 -0.37 -0.64 -867 -0.92 -1.09 -1.14 -13.3 -14.5 -13.9 - - -

EV/EBITDA

-2.2 -0.0 -0.9 -0.2 0.2 0.0 -0.1 -3.2 - - -

PEG

-0.0 -0.0 -0.0 0.0 -0.03 -0.01 -0.01 -0.06 -0.62 -0.21 - - -

P/B

-8.5 7.7 3.2 -62.0 39.9 1.3 0.5 1.7 1.3 2.5 - - -

P/CF

-1.1 -4.7 -4.3 -2.8 -1.3 -0.8 -2.7 -0.6 -1.9 -5.9 - - -

ROE %

597.53 -278.50 -99.85 2379088.12 -3235.71 -248.84 -86.54 -299.79 -81.23 -51.50 - - -

ROA %

-141.72 -70.61 -69.34 -362889.53 -191.65 -213.85 -80.67 -104.29 -50.62 -43.72 - - -

ROCE %

612.96 -282.44 -100.81 24936305.73 -783.71 -173.61 -27.76 -179.06 -60.06 -44.73 - - -

Current Ratio

0.8 1.3 3.3 0.9 1.1 6.6 8.6 2.2 4.7 6.6 - - -

DSO

- - - - - - - 876.8 - 7582.9 - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
2023202320222022202120212020202020192019201820182017201720162016201520152014201420132013201220122011201130000000 30000000 24000000 24000000 18000000 18000000 12000000 12000000 6000000 6000000 0 0 -6000000 -6000000
Download SVG
Download PNG
Download CSV

All numbers in USD currency

Quarterly Financial Ratios Daré Bioscience

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.55 1.53 -0.07 - -1.09 -1.22 -0.09 - -0.08 - -0.1 - -0.18 -0.18 -0.16 - -0.24 -0.27 -0.18 - -0.2 -0.29 -0.27 - -0.23 -0.32 -0.88 - -0.33 -0.55 -0.27 -0.17 -0.02 -3.97 -0.49 -0.39 -0.39 -0.37 -0.41 -0.37 -0.28 -0.44 -3.7 -4.45 -4.4 -7.96 -9.09 - - - - - - - -

EBITDA per Share

- - -0.06 - - - -0.1 - -0.08 - -0.1 - -0.18 -0.18 -0.17 - -0.24 -0.27 -0.18 - -0.2 -0.25 -0.27 - -0.23 -0.32 -0.88 - -0.27 -0.53 -0.18 - -0.01 -0.09 - - - - - - - - 0.05 - 0.22 0.2 0.12 - - - - - - - -

ROE %

1224.07 1269.90 1108.84 523.05 496.40 107.15 -213.81 -52.59 -92.32 -105.39 -224.97 -382.82 275.56 973.67 1710.56 1646.15 876.44 -551.65 -2066.81 -2358.61 -2396.88 -1665.45 -822.10 -205.49 -217.75 -191.73 -142.23 -17.84 678.03 692.55 613.48 512.03 22641.90 22617.98 22680.48 22766.49 -75.72 -66.34 -62.34 -51.50 -31.33 -15.68 5.84 18.18 14.49 11.10 5.91 - - - - - - - -

ROA %

-56.39 -63.47 -155.92 -97.36 -111.30 -92.11 -53.55 -30.20 -56.16 -68.17 -130.80 -157.40 -257.82 -332.29 -364.83 -251.09 -296.68 -241.85 -200.60 -139.70 -172.59 -159.89 -152.55 -176.59 -188.02 -166.55 -124.28 -16.63 -11100.60 -11125.27 -11150.59 -11184.81 -2383.69 -2361.08 -2344.94 -2319.77 -50.90 -47.82 -49.02 -43.72 -80.71 -117.14 -174.95 -251.11 -200.13 -153.29 -81.62 - - - - - - - -

ROCE %

- - - - -27.10 -54.20 -53.03 -53.14 -92.87 -105.50 -224.98 -394.18 264.12 962.14 1699.17 1646.36 870.88 -562.91 -2085.02 -2378.28 -2417.25 -1680.74 -831.22 -206.99 -217.03 -188.08 -137.61 -14.99 -15.08 -5.13 -3.33 -1.71 -1.71 -1.62 - - - - - - - - - - - - - - - - - - - - -

Current Ratio

0.9 1.1 0.5 0.8 0.9 0.9 1.2 1.3 2.1 2.8 2.7 3.3 2.9 2.1 1.4 0.9 0.9 0.9 0.9 1.1 1.1 1.1 1.1 7.1 7.1 7.1 7.1 14.8 14.8 14.8 14.8 0.1 0.1 - - 0.9 - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - 81.0 75.1 49.0 - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - 81.0 75.1 49.0 - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - 45.6 - - - - - - - - - - - - - - - - - - - 81.0 75.1 49.0 - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency